Considering the epigenetic changes upon FOXG1 KD in light of increasing inclusion of epigenetic drugs in clinical trials, we here highlight an attractive avenue for treatments of FOXG1-syndrome by epigenetic drugs. The gene discussed is FOXG1; the disease is Down syndrome.